MNDR at a glance
The past year
Chart−46.4% $0.95, close Nov 18
- From the highest close
- −80.0%
- Vs the 200-day average
- −27.4%
Short interest
History79,652 shares
- Since the last report
- +197.5%
- Days to cover
- 1.0 day
- Settled
- Oct 30, 2026
Insider buying, 7 days
FilingsNone filed this week
- Form 4s filed
- Nov 13 – Nov 19
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
MNDR price history
Loading recent earnings…
Investment thesis
What must happen next
Customers must treat MNDR’s mobile-health offering as a necessary access or workflow channel rather than discretionary digital-health spend, so lost demand can return without the company buying growth through discounts or promotions.WeakeningMateriality: High
GAAP annual revenue rose from $7.9 million in FY2023 ended June 30, 2023 to $14.0 million in FY2024 ended June 30, 2024, showing the platform has previously attracted materially higher demand. If customer pull returns, MNDR can rebuild the revenue base; if demand is structurally weak, the company remains too small to absorb fixed public-company and platform costs.
Watch: Healthcare customers standardize on hospital-owned telehealth portals or insurer/pharmacy apps instead of using MNDR’s platform.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue rose from $7.9 million in FY2023 ended June 30, 2023 to $14.0 million in FY2024 ended June.
Open source ↗MNDR needs enough platform differentiation, network control, or workflow value to avoid commodity pricing and provider-cost pressure; otherwise revenue recovery would not translate into attractive unit economics.HoldingMateriality: High
GAAP annual gross profit increased from $1.1 million in FY2023 ended June 30, 2023 to $2.5 million in FY2024 ended June 30, 2024 during the revenue upswing. Gross-profit quality determines whether growth can fund product, sales, and public-company costs instead of increasing losses.
Watch: Competing telehealth and healthcare-software platforms force MNDR to cut prices to retain customers.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual gross profit increased from $1.1 million in FY2023 ended June 30, 2023 to $2.5 million in FY2024 ended.
Open source ↗MNDR’s turnaround requires enough liquidity or non-punitive financing to bridge the period until demand and unit economics improve; otherwise capital structure, not product adoption, will drive shareholder outcomes.WeakeningMateriality: Medium
Cash was positive at $1.0 million as of June 30, 2025. A good operating recovery can still be poor for current owners if it is financed through distressed dilution.
Watch: MNDR cannot raise equity or debt on acceptable terms before the business reaches cash breakeven.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash was positive at $1.0 million as of June 30, 2025.
Open source ↗Management must turn the lower loss profile into a structural operating model improvement, not merely a smaller loss after cutting activity; otherwise MNDR remains dependent on external capital even if revenue stabilizes.HoldingMateriality: Medium
GAAP annual operating cash flow improved from negative $6.4 million in FY2024 ended June 30, 2024 to negative $4.4 million in FY2025 ended June 30, 2025. The owner needs evidence that the platform can self-fund; persistent cash burn transfers value from shareholders to future capital providers.
Watch: Customer acquisition costs rise because MNDR must spend heavily to rebuild demand after the FY2025 revenue decline.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow improved from negative $6.4 million in FY2024 ended June 30, 2024 to negative $4.4 million.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Customers must treat MNDR’s mobile-health offering as a necessary access or workflow channel rather than discretionary digital-health spend, so lost demand can return without the company buying growth through discounts or promotions. If customer pull returns, MNDR can rebuild the revenue base; if demand is structurally weak, the company remains too small to absorb fixed public-company and platform costs.
MNDR needs enough platform differentiation, network control, or workflow value to avoid commodity pricing and provider-cost pressure; otherwise revenue recovery would not translate into attractive unit economics. Gross-profit quality determines whether growth can fund product, sales, and public-company costs instead of increasing losses.
MNDR’s turnaround requires enough liquidity or non-punitive financing to bridge the period until demand and unit economics improve; otherwise capital structure, not product adoption, will drive shareholder outcomes. A good operating recovery can still be poor for current owners if it is financed through distressed dilution.
Management must turn the lower loss profile into a structural operating model improvement, not merely a smaller loss after cutting activity; otherwise MNDR remains dependent on external capital even if revenue stabilizes. The owner needs evidence that the platform can self-fund; persistent cash burn transfers value from shareholders to future capital providers.
All standing thesis claims
Original report summary
MNDR is a speculative mobile-health software turnaround whose value depends on proving that demand, gross margin, and cash burn can recover together before liquidity forces dilution.
Bull case and bear case
Bull case and bear case for Mobile-health Network Solutions
Where the evidence on Mobile-health Network Solutions disagrees: Mixed on the latest evidence (Oct 24, 2026). Of its 4 thesis points, 2 holding and 2 weakening.
Bull case: what the evidence supports
MNDR needs enough platform differentiation, network control, or workflow value to avoid commodity pricing and provider-cost pressure; otherwise revenue recovery would not translate into attractive unit economics.
Management must turn the lower loss profile into a structural operating model improvement, not merely a smaller loss after cutting activity; otherwise MNDR remains dependent on external capital even if revenue stabilizes.
Bear case: what the evidence questions
Customers must treat MNDR’s mobile-health offering as a necessary access or workflow channel rather than discretionary digital-health spend, so lost demand can return without the company buying growth through discounts or promotions.
MNDR’s turnaround requires enough liquidity or non-punitive financing to bridge the period until demand and unit economics improve; otherwise capital structure, not product adoption, will drive shareholder outcomes.
Thesis-Break Engine
Thesis-break watch · Mobile-health Network Solutions
No break has crossed Mobile-health Network Solutions’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedForeign issuer material report (6-K).
Mobile-health Network Solutions filed an SEC report on 2026-09-25: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Mobile-health Network Solutions filed an SEC report on 2026-08-18: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
- MixedForeign issuer material report (6-K).
Mobile-health Network Solutions filed an SEC report on 2026-08-12: Foreign issuer material report (6-K). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Healthcare customers standardize on hospital-owned telehealth portals or insurer/pharmacy apps instead of using MNDR’s platform.
- Competing telehealth and healthcare-software platforms force MNDR to cut prices to retain customers.
- MNDR cannot raise equity or debt on acceptable terms before the business reaches cash breakeven.
- Customer acquisition costs rise because MNDR must spend heavily to rebuild demand after the FY2025 revenue decline.
MNDR news
Loading headlines…
Financial statements
MNDR income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
MNDR: quick answers
- What is MNDR's short interest?
- As of October 30, 2026, 79,652 MNDR shares were sold short, up 197.5% from the count before. At the stock's average daily volume that is 1.0 day to cover. FINRA publishes the count twice a month. MNDR short interest history

